ES439017A1 - Un procedimiento para la preparacion de nuevas piridinas. - Google Patents

Un procedimiento para la preparacion de nuevas piridinas.

Info

Publication number
ES439017A1
ES439017A1 ES439017A ES439017A ES439017A1 ES 439017 A1 ES439017 A1 ES 439017A1 ES 439017 A ES439017 A ES 439017A ES 439017 A ES439017 A ES 439017A ES 439017 A1 ES439017 A1 ES 439017A1
Authority
ES
Spain
Prior art keywords
pyrimidines
compounds
formula
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES439017A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH APPLIC S SOC GEN DE
Original Assignee
RECH APPLIC S SOC GEN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH APPLIC S SOC GEN DE filed Critical RECH APPLIC S SOC GEN DE
Publication of ES439017A1 publication Critical patent/ES439017A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES439017A 1975-04-10 1975-06-30 Un procedimiento para la preparacion de nuevas piridinas. Expired ES439017A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7511154A FR2306697A1 (fr) 1975-04-10 1975-04-10 Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants

Publications (1)

Publication Number Publication Date
ES439017A1 true ES439017A1 (es) 1977-06-16

Family

ID=9153719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES439017A Expired ES439017A1 (es) 1975-04-10 1975-06-30 Un procedimiento para la preparacion de nuevas piridinas.

Country Status (12)

Country Link
US (1) US3984411A (es)
JP (1) JPS51118777A (es)
BE (1) BE829845A (es)
CA (1) CA1036597A (es)
CH (1) CH603626A5 (es)
DE (1) DE2528360A1 (es)
ES (1) ES439017A1 (es)
FR (1) FR2306697A1 (es)
GB (1) GB1502182A (es)
IT (1) IT1036400B (es)
LU (1) LU72743A1 (es)
NL (1) NL7507441A (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176972B (hu) * 1977-06-13 1981-06-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
DK1034174T3 (da) * 1997-11-05 2003-09-22 Neurosearch As Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
ES2295816T3 (es) 2003-01-14 2008-04-16 Arena Pharmaceuticals, Inc. Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
JP2006518763A (ja) * 2003-02-24 2006-08-17 アリーナ ファーマシューティカルズ, インコーポレイテッド グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2441775C (en) * 2003-09-23 2004-09-28 Westport Research Inc. Container for holding a cryogenic fluid
UA92150C2 (ru) * 2004-06-04 2010-10-11 Арена Фармасьютикалз, Инк. Замещенные производные арила и гетероарила как модуляторы метаболизма и для профилактики и лечения связанных с ним расстройств
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
CA2619093A1 (en) * 2005-09-16 2007-03-29 Arena Pharmaceuticals, Inc. Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
JP5657383B2 (ja) 2007-08-30 2015-01-21 ダウ アグロサイエンシィズ エルエルシー 2−(置換フェニル)−6−アミノ−5−アルコキシ、チオアルコキシ、およびアミノアルキル−4−ピリミジンカルボキシラート、ならびに除草剤としてのそれらの使用
CN103221391B (zh) 2010-01-27 2018-07-06 艾尼纳制药公司 (R)-2-(7-(4-环戊基-3-(三氟甲基)苄基氧基)-1,2,3,4-四氢环戊二烯并[b]吲哚-3-基)乙酸及其盐的制备方法
CN103539791B (zh) 2010-09-22 2017-01-11 艾尼纳制药公司 Gpr119 受体调节剂和对与其相关的障碍的治疗
CN107405332A (zh) 2015-01-06 2017-11-28 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
CA2986611C (en) 2015-06-15 2023-10-03 Nmd Pharma Aps Compounds for use in treating neuromuscular disorders
US10301262B2 (en) 2015-06-22 2019-05-28 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
EP3582772A1 (en) 2017-02-16 2019-12-25 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
US3261833A (en) * 1964-10-20 1966-07-19 Smith Kline French Lab 2,4-diamino-6-aminoalkoxy pyrimidines
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine

Also Published As

Publication number Publication date
FR2306697A1 (fr) 1976-11-05
GB1502182A (en) 1978-02-22
CA1036597A (fr) 1978-08-15
LU72743A1 (es) 1975-10-08
JPS51118777A (en) 1976-10-18
US3984411A (en) 1976-10-05
NL7507441A (nl) 1976-10-12
BE829845A (fr) 1975-12-04
FR2306697B1 (es) 1979-08-10
CH603626A5 (es) 1978-08-31
IT1036400B (it) 1979-10-30
DE2528360A1 (de) 1976-10-21

Similar Documents

Publication Publication Date Title
ES439017A1 (es) Un procedimiento para la preparacion de nuevas piridinas.
IE41724L (en) Diphenylsulphoxide derivatives
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ES477265A1 (es) Procedimiento para la preparacion de fosfato y sales de me- tronidazol.
JPS5231099A (en) Novel synthesizing of binblastineebincristine compound
MX168599B (es) Procedimiento para la preparacion de compuestos cefemicos
UA6016A1 (uk) Спосіб одержання 4-епідауноміціна
ES454709A1 (es) Un procedimiento para la preparacion de n-fosfonometil-gli- cina.
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
CH614448A5 (en) Process for the preparation of novel tertiary amines and their acid addition salts, and compounds thus prepared
ES418924A1 (es) Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas.
HUT38623A (en) Process for production of derivatives of n-substituated neuramin-acid
ES418114A1 (es) Un procedimiento para la preparacion de nuevas 5-metiltio pirimidinas.
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2406640A1 (fr) Production de 2,6-diaminonebularines
FR2355834A1 (fr) Procede de preparation des 1-phenyl-3-amino pyrazoles
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
ES373764A1 (es) Procedimiento para la obtencion de n-fluor-acetil-amino-me-til-ureas.
ES425809A1 (es) Procedimiento para la preparacion de compuestos tetracicli-cos sustituidos por amino.
JPS55157562A (en) Novel intermediate useful for production of antitumor compounds
GR79558B (es)
ES436902A1 (es) Procedimiento para la obtencion de hidrocloruro de carniti- na.
ES423484A1 (es) Procedimiento para la obtencion de derivados de estilbeno que contienen grupos sulfo.
ES404463A1 (es) Procedimiento para la produccion de 6-hidroxi-dihidro-ura- cilos.
FR2398738A1 (fr) Preparation de benzoylurees

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202